GALLBLADDER CARCINOMA

Clinical trials for GALLBLADDER CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GALLBLADDER CARCINOMA trials appear

Sign up with your email to follow new studies for GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 6 Not yet finished but already full! 7 Completed 1 Terminated 3

Experimental Vaccine-Like therapy targets Hard-to-Treat cancers

Disease control Completed

This early-phase trial tested an experimental immunotherapy called ELI-002 in 25 people with KRAS-mutated pancreatic, colorectal, lung, ovarian, or bile duct cancers who had signs of remaining disease after standard treatment. The therapy aims to train the immune system to attack…

Matched conditions: GALLBLADDER CARCINOMA

Phase: PHASE1 • Sponsor: Elicio Therapeutics • Aim: Disease control

Last updated Jun 26, 2026 13:30 UTC

GALLBLADDER CARCINOMA

Get alerted when new GALLBLADDER CARCINOMA trials appear

Experimental Vaccine-Like therapy targets Hard-to-Treat cancers